[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Image left, text right» _builder_version=»4.16″ custom_padding=»0|0px|0px|0px|false|false» locked=»off» global_colors_info=»{}»][et_pb_row column_structure=»1_2,1_2″ use_custom_gutter=»on» custom_padding_last_edited=»on|tablet» padding_top_bottom_link_2=»true» padding_left_right_link_2=»false» _builder_version=»4.16″ width=»100%» width_tablet=»80%» width_phone=»80%» width_last_edited=»on|tablet» max_width=»100%» max_width_tablet=»80%» max_width_phone=»80%» max_width_last_edited=»on|tablet» module_alignment=»left» custom_margin=»|auto|-198px|auto|false|» custom_padding=»0|12%|0px|0px|false|false» custom_padding_tablet=»|0%||» custom_padding_phone=»» module_alignment_tablet=»center» module_alignment_phone=»center» module_alignment_last_edited=»on|tablet» use_custom_width=»on» width_unit=»off» custom_width_percent=»100%» locked=»off» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.16″ custom_padding=»|||» global_colors_info=»{}» custom_padding__hover=»|||»][et_pb_image src=»https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/49595699338_81be1e4850_o-scaled-1.jpg» alt=»St. Basil’s Cathedral in Moscow Russia» title_text=»The Russian Market» show_bottom_space=»off» force_fullwidth=»on» align_tablet=»center» align_phone=»center» align_last_edited=»on|desktop» _builder_version=»4.16″ background_color_gradient_direction=»90deg» background_color_gradient_start=»#404451″ background_color_gradient_end=»rgba(240,242,246,0)» custom_padding=»|150px|||false|false» custom_padding_tablet=»||60px|» custom_padding_phone=»||10px||false|false» custom_padding_last_edited=»on|phone» animation_style=»slide» animation_direction=»left» animation_intensity_slide=»1%» global_colors_info=»{}»][\/et_pb_image][et_pb_text _builder_version=»4.16″ _module_preset=»default» text_font_size=»13px» custom_padding=»|||61px||» global_colors_info=»{}»]<\/p>\n
Featured image: <\/span>Pedro Szekely, St. Basil’s Cathedral, Moskow<\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.16″ custom_padding=»6vw||6vw|» custom_padding_tablet=»0px|0px|0px|0px|false|true» custom_padding_phone=»||||false|false» custom_padding_last_edited=»on|tablet» global_colors_info=»{}» padding_phone=»||||false|false» padding_tablet=»|10%||10%|false|true» padding_last_edited=»on|tablet» custom_padding__hover=»|||»][et_pb_text _builder_version=»4.17.4″ text_font=»||||||||» header_font=»||||||||» header_3_text_color=»#3550a0″ header_6_font=»||||||||» max_width=»1157px» custom_margin=»-79px|-16px||-173px||» custom_padding=»|||20px||» hover_enabled=»0″ header_3_font_size_tablet=»» header_3_font_size_phone=»20px» header_3_font_size_last_edited=»on|desktop» locked=»off» global_colors_info=»{}» sticky_enabled=»0″]<\/p>\n <\/p>\n The Russian Consumer Healthcare and Pharma market experienced a few changes over the past years that solidated the growth and opportunities this market has to offer.\u00a0<\/span><\/i><\/p>\n The Russian OTC and pharma markets have experienced stable growth in the last few years, further outlining the obstinacy of the market. In 2021, the consumer health and Rx market accounted for <\/span>21,35 billion USD<\/b>. Forecasts further predict the growth of approximately 16% in the next few years.<\/span> The OTC & Pharma Market<\/b> should reach USD 35,86 Billion ex-factory<\/b> in 2035<\/b>.\u00a0\u00a0<\/span><\/p>\n The market is divided into three segments: the commercial self-medication and prescription drug, the commercial parapharmaceutical, and the governmental segments. The first of these is the largest by far.\u00a0<\/span><\/p>\n Further, the market can be divided into three other main groups of participants: <\/span>Due to its focus on <\/span>imports, representing 55,6% of the sales in 2021<\/b>, as well as the geographical characteristics of Russia, a great deal of attention is paid to the wholesale sector. <\/span>Pharmaceutical distributors provide access to foreign drugs and allow for the distribution of drugs produced locally. Leaders in this area\u2014along with leaders in drug production\u2014are quite stable. Distributors are trying to expand their networks with branches in many cities to ensure the stable flow of the required number of products.<\/span><\/p>\n The Russian Rx segment is almost equal to the OTC sector, but sales in both sectors have been increasing from year to year. In 2021, according to the DSM report, Rx products represented 52,6% of sales and OTC products 47,4%.\u00a0\u00a0<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=»4.17.4″ _module_preset=»default» custom_padding=»0px|||||» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» header_3_text_color=»#001389″ global_colors_info=»{}»]<\/p>\n The domestic Russian pharma market faces a number of <\/span>obstacles and difficulties <\/b>that seriously complicate and hinder its development.\u00a0<\/span><\/p>\n Currently <\/span>government regulations<\/b> have a very large impact on the domestic pharma market of the Russian Federation; strategies for the replacement of imported drugs with Russian ones are being developed. For example, Russia pharma producers remain in a leading position when working with vital and essential drugs, because surcharges depend on the manufacturer\u2019s price. The launch of new drugs is also one of the most important areas of the market. Many importers are increasingly looking for the opportunity to start their own contracts for production in Russia. The state seeks to support and motivate foreign pharmaceutical companies to engage in this kind of cooperation, because it generates the opportunity both to create new jobs and to improve cash flows to the state budget.<\/span><\/p>\n The government is actively taking measures to regulate the pharmaceutical market, in particular by increasing local production.\u00a0<\/span><\/p>\n It must be said that the pandemic has not had any major impact on the development prospects of the Russian producers. One of the development priorities in this agenda is the <\/span>Pharma-2030 Strategy<\/b>. This strategy implemented by the government aim at improving the production of products. In the next decade, they plan on slowly shifting their OTC and pharma market towards a localization of the production to reduce their imports of medicine.\u00a0<\/span><\/p>\n As a result, the Russian Pharma industry is currently under reconstruction and modernization. The state is expending considerable effort to allow domestic manufacturers to lead the field. But the success of these initiatives will only be seen in the next few years, when the planned strategies are implemented.<\/span><\/p>\n We, Chameleon Pharma Consulting, have experts with a minimum of twenty years of experience in the global healthcare industry, including the Russian Consumer health and Pharma Market in Regulatory and GMP Audits. This experience has been accrued by working on numerous projects, from internationalizing products to optimizing individual international pharma strategies. We are active in segments such as Consumer Health, Pharma, Medical Devices and Cosmetics, and are here to support your business and plans for engaging in Emerging Markets worldwide. For more information on our services, please continue browsing our website.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Expert Knowledge» _builder_version=»4.16″ _module_preset=»default» min_height=»609.2px» custom_margin=»4px||-121px|||» custom_padding=»0px|||||» locked=»off» global_colors_info=»{}»][et_pb_row admin_label=»Row» _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» min_height=»45px» custom_padding=»||0px|||» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_2,1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_icon font_icon=»||divi||400″ icon_color=»#001389″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][\/et_pb_icon][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n OTC and pharma market size, ex-factory<\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=»1_2″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_icon font_icon=»||divi||400″ icon_color=»#001389″ _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»][\/et_pb_icon][et_pb_text _builder_version=»4.17.4″ _module_preset=»default» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»]<\/p>\n OTC and pharma market growth<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ admin_label=»Number Counter» _builder_version=»4.16″ _module_preset=»default» background_color=»#EEEEEE» min_height=»603px» custom_margin=»-33px|||||» custom_padding=»2px|||||» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_text _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_3,1_3,1_3″ use_custom_gutter=»on» gutter_width=»1″ _builder_version=»4.16″ _module_preset=»default» width=»91%» max_width=»2486px» global_colors_info=»{}»][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Total population» number=»142 320 790″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» title_font_size=»19px» number_text_color=»#0B0B7A» number_font_size=»58px» width=»100%» custom_margin=»||55px|||» custom_padding=»|||0px||» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Male\/Female ratio» number=»0.86″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» number_font_size=»59px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Population growth» number=»-0.2%» percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» number_font_size=»59px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=»1_3,1_3,1_3″ use_custom_gutter=»on» gutter_width=»1″ _builder_version=»4.16″ _module_preset=»default» width=»91%» max_width=»2486px» global_colors_info=»{}»][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Birth rate» number=»9.71\/1000″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» title_font_size=»19px» number_text_color=»#0B0B7A» number_font_size=»53px» width=»100%» custom_margin=»||55px|||» custom_padding=»|||0px||» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Mortality rate» number=»13.4\/1000″ percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» title_font_size=»18px» number_text_color=»#0B0B7A» number_font_size=»57px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][et_pb_column type=»1_3″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_number_counter title=»Life expectancy» number=»72.12 years» percent_sign=»off» _builder_version=»4.16″ _module_preset=»default» number_text_color=»#0B0B7A» number_font_size=»58px» global_colors_info=»{}»][\/et_pb_number_counter][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=»1″ _builder_version=»4.16″ _module_preset=»default» locked=»off» global_colors_info=»{}»][et_pb_row _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_column type=»4_4″ _builder_version=»4.16″ _module_preset=»default» global_colors_info=»{}»][et_pb_cta title=»Interested in this market?» button_url=»https:\/\/www.chameleon-pharma.com\/about\/contacts\/» button_text=»Click Here» _builder_version=»4.16″ _module_preset=»default» background_color=»#0B0B7A» global_colors_info=»{}»]<\/p>\n We are ready to support you in\u00a0<\/span>Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory\u00a0projects, and more in order to ensure your growth.<\/span><\/p>\n [\/et_pb_cta][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Russia\u00a0Featured image: Pedro Szekely, St. Basil’s Cathedral, MoskowRussia: an enticing Consumer Healthcare and Pharma market\u00a0 The Russian Consumer Healthcare and Pharma market experienced a few changes over the past years that solidated the growth and opportunities this market has to offer.\u00a0 Market Structure The Russian OTC and pharma markets have experienced stable growth in […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8782,"menu_order":16,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"\u00a0\r\n\r\n[caption id=\"attachment_1927\" align=\"alignleft\" width=\"408\"]Russia: an enticing Consumer Healthcare and Pharma market\u00a0<\/strong><\/h2>\n
Market Structure<\/b><\/h3>\n
Segments<\/b><\/h3>\n
Economic Groups<\/b><\/h3>\n
OTC vs. RX<\/b><\/h3>\n
Reasons for the prosperous market and remaining difficulties<\/b><\/h3>\n
Governmental actions and future plans<\/b><\/h3>\n
Our added value<\/b><\/h3>\n
The Russian OTC and pharma market in 2035<\/h2>\n
USD 35,86 Billion<\/b><\/h3>\n
3-6%<\/strong><\/h3>\n
Russia in a few numbers<\/h2>\n
![\"https:\/\/www.flickr.com\/photos\/ranopamas\/3296032508\/\"](\"https:\/\/www.chameleon-pharma.com\/wp-content\/uploads\/2016\/04\/3296032508_c5c54094d7_z.jpg\")
Saint-P\u00e9tersbourg - Cath\u00e9drale Notre-Dame de Kazan - 15-02-2009 - 9h22 <\/a>by Panoramas<\/a>[\/caption]\r\n\r\nThe Russian pharmaceutical market is one of the fastest-growing markets worldwide with an annual growth over ten percent during the last couple of years.\r\n\r\nIn 2015, the pharmaceutical market in Russia grew by almost 12% in value terms compared to the previous year and accounted for 16.5 billion USD (1.28 trillion RUB). Forecasts further predict a growth of approximately 8% in 2016. According to market experts, this steady market growth is mainly due to inflation and growing drug prices, caused by the devaluation of the local currency. The pharmaceutical industry can be seen as the most sustainable segment of the Russian economy due to its strong social impact. Although the Russian pharmaceutical market has a huge potential, a long-term growth forecast is not possible due to the unstable political and economic situation.\r\n\r\nIn 2014, domestic dugs accounted for about a quarter of the Russian pharmaceutical retail market in value terms; however, they dominated the market in volume terms with a share of 55.3% at the same time. Although imported drugs are still important for the Russian market, foreign manufacturers, especially those producing medicines that are on the list of vital drugs, currently produce at a loss due to the ongoing devaluation of the rouble.\r\nCompared to other countries, the Russian pharmaceutical market was ranked seventh among all major global pharmaceutical markets, with the largest market being in the USA. In contrast with the EU and the USA, however, the Russian pharmaceutical market is mainly controlled by the commercial segment rather than government purchasing.","_et_gb_content_width":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8854","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/comments?post=8854"}],"version-history":[{"count":13,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8854\/revisions"}],"predecessor-version":[{"id":17489,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8854\/revisions\/17489"}],"up":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/pages\/8782"}],"wp:attachment":[{"href":"https:\/\/www.chameleon-pharma.com\/ru\/wp-json\/wp\/v2\/media?parent=8854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}